Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma.

AIMS Radiotherapy treatment planning for high-grade gliomas (HGG) is hampered by the inability to image peri-tumoural white-matter infiltration. Diffusion tensor imaging (DTI) is an imaging technique that seems to show white-matter abnormalities resulting from tumour infiltration that cannot be visualised by conventional computed tomography or magnetic resonance imaging (MRI). We propose a new term, the image-based high-risk volume (IHV) for such abnormalities, which are distinct from the gross-tumour volume (GTV). For IHV based on DTI, we use the term IHVDTI. This study assesses the value of DTI for the individualisation of radiotherapy treatment planning for patients with HGG. METHODS Seven patients with biopsy-proven HGG were included in a theoretical planning exercise, comparing standard planning techniques with individualised plans based on DTI. Standard plans were generated using a 2.5 cm clinical target volume (CTV) margin added to the GTV. For DTI-based plans, the CTV was generated by adding a 1 cm margin to the IHVDTI. Estimates of normal tissue complication probability (NTCP) were calculated and used to estimate the level of dose escalation that could be achieved using the DTI-based plans. RESULTS The use of DTI resulted in non-uniform margins being added to the GTV to encompass areas at high risk of tumour involvement, but, in six out of seven cases, the IHVDTI was encapsulated by the standard CTV margin. In all cases, DTI could be used to reduce the size of the planning-target volume (PTV) (mean 35%, range 18-46%), resulting in escalated doses (mean 67 Gy, range 64-74 Gy), with NTCP levels that matched the conventional treatment plans. CONCLUSION DTI can be used to individualise radiotherapy target volumes, and reduction in the CTV permits modest dose escalation without an increase in NTCP. DTI may also be helpful in stratifying patients according to the degree of white-matter infiltration.

[1]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  N. Bleehen,et al.  A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. , 1991, British Journal of Cancer.

[3]  A Brahme,et al.  Tumour and normal tissue responses to fractionated non-uniform dose delivery. , 1992, International journal of radiation biology.

[4]  M Schwaiger,et al.  First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. , 2000, International journal of radiation oncology, biology, physics.

[5]  Benedick A Fraass,et al.  Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  U Oppitz,et al.  3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. , 1999, Radiotherapy and Oncology.

[7]  P. Rubin,et al.  High dose radiation therapy in the treatment of malignant gliomas: final report. , 1979, International journal of radiation oncology, biology, physics.

[8]  J D Pickard,et al.  Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? , 2003, Clinical radiology.

[9]  F. Heppner,et al.  Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[11]  A. Pena,et al.  Detecting glioma invasion of the corpus callosum using diffusion tensor imaging , 2004, British journal of neurosurgery.

[12]  Y. Akine,et al.  Radiation therapy for advanced gastric cancer. , 1988, International journal of radiation oncology, biology, physics.

[13]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[14]  S. Benedict,et al.  Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation. , 1998, Radiation oncology investigations.

[15]  Colin Studholme,et al.  An overlap invariant entropy measure of 3D medical image alignment , 1999, Pattern Recognit..

[16]  R. Mohan,et al.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.

[17]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[18]  W. Regine,et al.  Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. , 2000, Journal of neurosurgery.

[19]  David A Mankoff,et al.  Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[21]  A. Hopkins,et al.  Malignant cerebral glioma—I: Survival, disability, and morbidity after radiotherapy , 1996, BMJ.

[22]  C. Thilmann,et al.  Intensity‐modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high‐grade gliomas , 2001, International journal of cancer.

[23]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[24]  P Okunieff,et al.  Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. , 1999, Journal of neurosurgery.

[25]  Fred H. Hochberg,et al.  Assumptions in the radiotherapy of glioblastoma , 1980, Neurology.

[26]  T. A. Carpenter,et al.  Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas , 2004, European Radiology.

[27]  A. Gregor,et al.  Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  Mitchel S Berger,et al.  3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. , 2004, International journal of radiation oncology, biology, physics.

[29]  M. Walker,et al.  An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. , 1979, International journal of radiation oncology, biology, physics.

[30]  N G Burnet,et al.  Accuracy of patient positioning during radiotherapy for bladder and brain tumours. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).